NCT07311993 2026-04-14Phase 1 Study of CLR 125 in Triple Negative Breast CancerCellectar Biosciences, Inc.Phase 1 Recruiting60 enrolled
NCT05610891 2026-03-18Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGGCellectar Biosciences, Inc.Phase 1 Active not recruiting50 enrolled